IMA
Price
$17.28
Change
-$0.62 (-3.46%)
Updated
Aug 1 closing price
Capitalization
192.77M
5 days until earnings call
TRML
Price
$21.76
Change
-$1.58 (-6.77%)
Updated
Aug 1 closing price
Capitalization
558.98M
Interact to see
Advertisement

IMA vs TRML

Header iconIMA vs TRML Comparison
Open Charts IMA vs TRMLBanner chart's image
ImageneBio
Price$17.28
Change-$0.62 (-3.46%)
Volume$11.73K
Capitalization192.77M
Tourmaline Bio
Price$21.76
Change-$1.58 (-6.77%)
Volume$226.85K
Capitalization558.98M
IMA vs TRML Comparison Chart in %
Loading...
IMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRML
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMA vs. TRML commentary
Aug 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMA is a Hold and TRML is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 02, 2025
Stock price -- (IMA: $17.28 vs. TRML: $21.76)
Brand notoriety: IMA and TRML are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMA: 4% vs. TRML: 98%
Market capitalization -- IMA: $192.77M vs. TRML: $558.98M
IMA [@Biotechnology] is valued at $192.77M. TRML’s [@Biotechnology] market capitalization is $558.98M. The market cap for tickers in the [@Biotechnology] industry ranges from $213.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMA’s FA Score shows that 1 FA rating(s) are green whileTRML’s FA Score has 1 green FA rating(s).

  • IMA’s FA Score: 1 green, 4 red.
  • TRML’s FA Score: 1 green, 4 red.
According to our system of comparison, both IMA and TRML are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMA’s TA Score shows that 5 TA indicator(s) are bullish while TRML’s TA Score has 6 bullish TA indicator(s).

  • IMA’s TA Score: 5 bullish, 3 bearish.
  • TRML’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both IMA and TRML are a good buy in the short-term.

Price Growth

IMA (@Biotechnology) experienced а +1108.39% price change this week, while TRML (@Biotechnology) price change was +10.07% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.14%. For the same industry, the average monthly price growth was +15.55%, and the average quarterly price growth was +36.18%.

Reported Earning Dates

IMA is expected to report earnings on Nov 06, 2025.

TRML is expected to report earnings on May 02, 2025.

Industries' Descriptions

@Biotechnology (+0.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRML($559M) has a higher market cap than IMA($193M). IMA YTD gains are higher at: 953.659 vs. TRML (7.298).
IMATRMLIMA / TRML
Capitalization193M559M35%
EBITDAN/A-98.41M-
Gain YTD953.6597.29813,068%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A249M-
Total DebtN/A196K-
TECHNICAL ANALYSIS
Technical Analysis
IMATRML
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 4 days ago
85%
Declines
ODDS (%)
N/A
Bearish Trend 13 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
IMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRML
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ABNAF0.05N/A
N/A
Aben Gold Corp.
MIZUF18.00N/A
N/A
Mizuno Corp.
IREHF0.24N/A
N/A
Integrated Research Ltd.
MNRIF0.29N/A
N/A
Minor International Public Co., Ltd.
MTUAF429.15-5.43
-1.25%
MTU Aero Engines AG

IMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMA has been closely correlated with CELC. These tickers have moved in lockstep 87% of the time. This A.I.-generated data suggests there is a high statistical probability that if IMA jumps, then CELC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMA
1D Price
Change %
IMA100%
-3.46%
CELC - IMA
87%
Closely correlated
+1.90%
MRSN - IMA
65%
Loosely correlated
-3.65%
SLXN - IMA
59%
Loosely correlated
-37.88%
TRML - IMA
23%
Poorly correlated
-6.77%
MNOV - IMA
23%
Poorly correlated
+7.92%
More

TRML and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRML has been closely correlated with SPHDF. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if TRML jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRML
1D Price
Change %
TRML100%
-6.77%
SPHDF - TRML
78%
Closely correlated
N/A
STOK - TRML
46%
Loosely correlated
+0.47%
IMNM - TRML
46%
Loosely correlated
+0.67%
IDYA - TRML
43%
Loosely correlated
-0.33%
IPSC - TRML
43%
Loosely correlated
-2.87%
More